Vendor, San Diego, CA
Arcturus Therapeutics, Inc.
UEI E3MFDBN4L3J9, CAGE 6X1L5
1 award and $0 obligated between March 7, 2024 and March 20, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50122C00007Definitive Contract, March 7, 2024, Not Competed, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Procure a Pandemic Influenza Vaccine (Pandflu) and a Quadrivalent Seasonal Influenza Vaccine (Qsflu)NAICS 541714, PSC AN14 | $0 |
- Places of performance
- California
- Product and service codes
- AN14 Health R&D Services; Health Care Services; R&D Administrative Expenses
- Transactions
- 5 across 1 awards